Pygeum (Prunus africana) Prostate Supplements: What to Compare Before Buying

The bark extract is the product identity

Pygeum refers to preparations derived from the bark of Prunus africana. For buyers, “pygeum” on the front panel is incomplete information. The comparison should focus on bark extract amount, extract identity or standardization, daily serving and whether the product is single-ingredient or combined with saw palmetto, nettle or phytosterols.

The evidence is mostly old and short-term

A systematic review of 18 randomized trials involving 1,562 men found modest short-term improvements in overall urinary symptoms and flow measures, including signals for nocturia and residual urine. But the average study lasted only about two months, study quality varied and preparations differed. That makes pygeum a classic case where historical evidence should not be presented as a modern certainty.

Nocturia claims need special restraint

Because older pygeum analyses reported a reduction in nocturia, marketers may build strong nighttime-urination claims around that number. A buyer should remember that nocturia has many causes, from evening fluid intake and sleep disorders to bladder problems and diabetes. A botanical study in men with BPH does not diagnose the cause of someone’s nighttime urination.

Best use of this page: identify a transparent extract

The practical decision is whether the manufacturer clearly identifies the bark extract and dose, cites evidence accurately, avoids disease-treatment promises and provides warnings. Pygeum pages should help compare preparations, not turn a decades-old meta-analysis into a guarantee.

Because preparations varied, a modern buyer should look for an identified Prunus africana bark extract rather than assuming every “pygeum 500 mg” product corresponds to the old clinical material. Dose weight alone cannot solve an extract-identity problem.

The classic meta-analysis covered 18 randomized trials and 1,562 men, but the mean study duration was only about 64 days. The review reported roughly 19% less nocturia, 24% lower residual urine and 23% higher peak flow in pooled analyses. Those numbers are interesting, not a license to promise long-term disease control.

Ingredient-specific evidence audit

• Pygeum refers to preparations derived from the bark of Prunus africana. For buyers, “pygeum” on the front panel is incomplete information. The comparison should focus on bark extract amount, extract identity or standardization, daily serving and whether the pr…
• A systematic review of 18 randomized trials involving 1,562 men found modest short-term improvements in overall urinary symptoms and flow measures, including signals for nocturia and residual urine. But the average study lasted only about two months, study qua…
• Because older pygeum analyses reported a reduction in nocturia, marketers may build strong nighttime-urination claims around that number. A buyer should remember that nocturia has many causes, from evening fluid intake and sleep disorders to bladder problems a…
• The practical decision is whether the manufacturer clearly identifies the bark extract and dose, cites evidence accurately, avoids disease-treatment promises and provides warnings. Pygeum pages should help compare preparations, not turn a decades-old meta-anal…
• Because preparations varied, a modern buyer should look for an identified Prunus africana bark extract rather than assuming every “pygeum 500 mg” product corresponds to the old clinical material. Dose weight alone cannot solve an extract-identity problem.
• The classic meta-analysis covered 18 randomized trials and 1,562 men, but the mean study duration was only about 64 days. The review reported roughly 19% less nocturia, 24% lower residual urine and 23% higher peak flow in pooled analyses. Those numbers are int…

Ingredient-specific buyer checklist

• Pygeum refers to preparations derived from the bark of Prunus africana. For buyers, “pygeum” on the front panel is incomplete information. The comparison should focus on bark extract amount, extract identity or standardization, daily serving and whether the pr…
• A systematic review of 18 randomized trials involving 1,562 men found modest short-term improvements in overall urinary symptoms and flow measures, including signals for nocturia and residual urine. But the average study lasted only about two months, study qua…
• Because older pygeum analyses reported a reduction in nocturia, marketers may build strong nighttime-urination claims around that number. A buyer should remember that nocturia has many causes, from evening fluid intake and sleep disorders to bladder problems a…
• The practical decision is whether the manufacturer clearly identifies the bark extract and dose, cites evidence accurately, avoids disease-treatment promises and provides warnings. Pygeum pages should help compare preparations, not turn a decades-old meta-anal…
• Because preparations varied, a modern buyer should look for an identified Prunus africana bark extract rather than assuming every “pygeum 500 mg” product corresponds to the old clinical material. Dose weight alone cannot solve an extract-identity problem.
• The classic meta-analysis covered 18 randomized trials and 1,562 men, but the mean study duration was only about 64 days. The review reported roughly 19% less nocturia, 24% lower residual urine and 23% higher peak flow in pooled analyses. Those numbers are int…

Ingredient-specific buyer checklist

Quick decision matrix

Bottom line

The practical decision is whether the manufacturer clearly identifies the bark extract and dose, cites evidence accurately, avoids disease-treatment promises and provides warnings. Pygeum pages should help compare preparations, not turn a decades-old meta-analysis into a guarantee. Ingredient education is separate from SoYoungPlus formula claims. Confirm the current product label before assuming this ingredient is included.

Related ingredient guides

• Saw Palmetto (Serenoa repens)
• Beta-Sitosterol
• Nettle Root (Urtica dioica)
• Zinc

Evidence and further reading

Pygeum (Prunus africana) — authoritative evidence source

Frequently asked questions